Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil
BMC Women's Health volume 13, Article number: 6 (2013)
Lymphedema is a highly prevalent condition in women who have undergone treatment for breast cancer. Lymphedema negatively affects the quality of life. The objective of this study was to estimate the prevalence of lymphedema and associated factors in women treated for breast cancer in the municipality of Juiz de Fora.
We performed a cross-sectional study that evaluated 250 women who were being treated for breast cancer. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded. Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment.
The prevalence of lymphedema was 44.8%. There were medical records on the presence of this condition in 5.4% of cases. With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema. Variables, including the presence of seroma, vascular changes, time elapsed after surgery, episodes of redness in the extremities, and cuticle removal from the hand with pliers were considered as major associated factors for lymphedema (p<0.05).
The prevalence of 44.8% for lymphedema found in this study is considered to be relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. The planning of health programs and services appropriate for the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize the morbidity of this disease.
Breast cancer is considered the second leading cause of mortality and morbidity among women in Brazil . The approaches used to control and treat breast cancer have been well studied to the extent that they have led to increased survival of these women . Therefore, there is growing interest in seeking resources and alternatives that could improve the quality of life of breast cancer patients [3–6]. There is also a need to understand the behavior of morbidities from breast cancer that may occur because of tumor development and the therapies used. There is still a high number of late diagnoses that contribute to the election of more aggressive therapy and subsequent traumatic surgery [2, 7, 8]. This necessitates the improvement of therapeutic techniques to reduce the number of comorbidities presented. Among the notable major innovations are breast surgery techniques and axillary approaches, such as sentinel lymph node (SLN) biopsy [7–10]. Even with the use of these approaches, studies show a high prevalence of postoperative morbidities, mainly regarding lymphedema [7, 11–13]. This condition arises from disruption of the lymphatic system in coping with the axillary approach for staging or control of the disease [8, 14]. Recent studies on the prevalence of lymphedema and associated factors in specific populations show varying results [8, 9, 15, 16] possibly owing to differing diagnostic methods for detection of lymphedema and to sampling differences. Improving the knowledge regarding risk factors specifically associated with lymphedema in a given population will aid in the formulation of protocols for both its prevention and its treatment, enabling an improved quality of life for these women.
In the municipality of Juiz de Fora, Minas Gerais, southeastern Brazil, there are cancer treatment centers extending services to neighboring micro and macro regions, thus offering a potent sampling source for research in the area.
This study aimed to ascertain the prevalence of lymphedema in women undergoing treatment for breast cancer in a referral unit for cancer treatment in the municipality of Juiz de Fora, as well as associated risk factors. We hypothesized that the prevalence of lymphedema is high and is associated with the time elapsed since surgery and comorbidities among these women.
During the period from August 2009 to June 2010, a total of 250 women, who came to the clinic for an oncology (chemotherapy and/or radiotherapy) follow-up visit, were evaluated at a specialized hospital in the municipality of Juiz de Fora. Pre-screening of the sample by analysis of medical records was performed to select women who met the inclusion criteria as follows: women who had an operation more than 6 months ago; absence of active disease, locoregional or distant; the absence of functional change in the affected limb before surgery, which could lead to swelling of the limb; and simulating or masking symptoms of lymphedema, such as bursitis, tendonitis, and work-related musculoskeletal disorders.
All eligible women were invited to participate in the study, and upon signing the consent form, only four women refused to participate. Women with bilateral breast cancer, absence of axillary intervention (partial or complete axillary dissection and/or SLN biopsy), active disease in the region, or lympho-venous alteration of the limb before surgery were excluded.
Data were collected from the medical records of the selected cases, and they subsequently underwent an interview and a physical assessment. Records were analyzed to obtain data regarding the treatment of breast cancer, axillary intervention, seromas, vascular implications, and tumor staging. A semi-structured questionnaire was used for subjective diagnosis of lymphedema and its possible associated factors, followed by the administration of a physical examination for clinical diagnosis and detection of co-existing morbidities. The elapsed time from surgery until the date of the interview was divided into two categories: beyond or within 5 years. Current pain was estimated using the Visual Analog Scale categorized into 10 recording intervals for de-registration.
The physical examination was performed by only one evaluator, who was qualified and trained for this type of approach. The criterion for the diagnosis of lymphedema was obtained by perimetry with the use of a measuring tape, with measurements obtained after adjustment of the dominant arm and time since diagnosis [7, 14]. Measurements were taken at seven points: at the inside of the elbow in the supine position (taken as the zero point), and three measurements above and below this point, at intervals of 7.0 cm. Lymphedema was characterized as when the difference between the affected limb and the contralateral (control) limb, using at least one measurement, was equal to or greater than 2.0 cm [7, 12, 14, 17]. This study met the requirements of the Declaration of Helsinki and was approved by the Institutional Ethics Committee of the Federal University of Juiz de Fora (reference number: 050/2009).
The data were processed in a database created with the Statistical Package for Social Sciences version 14.0 (SPSS Inc., Chicago, IL) and Stata 10.0 (StataCorp, Texas). The significance level of the study was 95% (p≤0.05). The presence or absence of lymphedema was considered the dependent variable. The independent variables were aggregated and analyzed in blocks, combined with socio-demographic and health self-assessment variables, characteristics concerning the diagnosis and treatment of cancer, symptoms and presence of Axillary Web Syndrome (AWS) or superficial lymphatic thrombosis in the upper limb ipsilateral to surgery in the postoperative period, information regarding the care and early movement of the limb ipsilateral to surgery, and variables associated with lymphedema in women after surgical treatment of breast cancer. These factors were adjusted for variables on self-reported morbidities, treatment characteristics, and postoperative characteristics. Descriptive analysis was used to obtain absolute and relative frequencies of the analysis variables, as well as for the prevalence of the outcome investigated. Bivariate analysis was performed to assess the association of each independent variable with the dependent variable, using the chi-square (χ2) test. In multivariate analysis, Poisson regression was used to analyze the independent variables associated with outcome, controlling for potential confounders, such as the dominant arm and time since diagnosis (adjusted prevalence ratio). The Poisson regression in each block of analysis combined variables with a crude p-value <0.20, and between the blocks, the adopted significance was 5%. The significance level was tested using the Wald test for heterogeneity and linear trend.
The prevalence of lymphedema in the upper limb ipsilateral to breast surgery was 44.8% (112/250 women). There were medical records on the presence of this condition in 5.4% of cases (6/250 cases). The time elapsed after surgery was significantly associated with the prevalence of lymphedema (p=0.028).
With regard to variables from the postoperative period, the presence of seroma and symptoms, such as redness, were significantly associated with lymphedema (p<0.001) after adjustment by the regression model (Table 1).
Physical examination showed that 49.6% (124/250) of the women with lymphedema had superficial lymphatic thrombosis, which demonstrated an association with lymphedema in bivariate analysis (p<0.001).
The mean age of patients with lymphedema was 56±11,58 and there was no significant difference in age compared with those without lymphedema (p=0.24). The two groups were similar with respect to variables, such as schooling (p=0.39), obesity (p=0.35), and skin color (p=0.15). In the presence of comorbidities, women with vascular implications (thrombosis, varicose veins, circulatory changes in the lower and/or upper limbs, and others) had a frequency of 2.7 times greater for developing lymphedema (p=0.02). There was no difference between the groups for other self-reported health conditions, including hypertension (p=0.30) and diabetes mellitus (p=0.49, Table 2).
Women who had undergone surgery more than 5 years previously had a 9.7 times higher frequency of lymphedema compared with those who had undergone surgery less than 5 years previously (p=0.02). The analysis of other variables related to cancer treatment is shown in Table 3.
With regard to shoulder joint mobility, restrictions on abduction movements, internal and external rotation, and anterior shoulder adduction were significantly associated with lymphedema (p<0.001).
There was no significant association with outcome for almost all of the variables related to information that the patients received from the healthcare team on caring for their limbs and guidance on early movement after surgery, except for the variable of cuticle removal from the hand with pliers. This variable remained associated with lymphedema even when adjusted for other variables, such as self-reported morbidities and characteristics of the implemented treatment (p=0.02, Table 4).
All variables that proved to be significant after adjustment within the block to which they belonged were subjected to Poisson regression to build the final model. Variables that remained significant were vascular disorders (p=0.08), the presence of redness in any region of the arm after surgery (p<0.001), the presence of seroma (p<0.001), and cuticle removal with pliers from the hand corresponding to the limb ipsilateral to surgery (p=0.013), because actual daily routine remained relevant in the model (Table 5).
The current study found that the prevalence of patients with lymphedema after treatment for breast cancer was 44.8%. However, it is possible that underestimation occurred because the average time spent in the postoperative period in our sample was 5 years, and the higher a woman’s exposure to risk factors, the greater the chances of developing lymphedema. The possibility of survival bias cannot be ruled out because more severe cases subjected to more drastic measures may not have maintained contact owing to death, and therefore were not included in this sample. The prevalence of lymphedema found in this study is higher than the prevalence rates between 9% and 40% reported by other studies [8, 9, 12, 15, 16, 18, 19]. This difference between prevalence rates could be attributed to the type of method used to diagnose lymphedema, because there are several methods for measuring arm volume, [7, 14, 17, 19] and because of the fact that the institution in which the data were collected does not offer a service specializing in prevention and treatment of lymphedema. Perimetry, which was the diagnostic method used in this study, is based on comparing the measurement of the circumference of the affected arm with the contralateral arm [7, 9, 14, 17]. Furthermore, in Brazil, delayed diagnosis is common, causing more aggressive surgeries, which could be an important reason for the high prevalence of lymphedema in this study.
Age is a variable often associated with lymphedema [7, 19–22]. Along with the aging process, anatomical and physiological changes related to lymphatic obstruction occur, which may predispose to the development of lymphedema, with the main mechanism being the opening of lympho-venous anastomoses [7, 22–24]. The higher incidence of lymphedema in older patients observed in some studies [7, 19, 23, 25] may be due to a progressive loss of these anastomoses because of the aging process [12, 24]. This finding was not observed in the current study, where the average age of the patients with lymphedema was 56 years, with no significant difference between those with and those without lymphedema. Likewise, a study by Yen et al.,  who investigated self-reporting of the risk factors for lymphedema in older women, also found no significant difference between women with and those without lymphedema. The difference in evaluation methods and the average age of the women involved in these studies may be responsible for the discrepancy of results.
In attempting to reestablish the lympho-venous balance of the upper limb and breast region after breast cancer treatment, the body makes use of compensatory mechanisms, which attempt to avoid edema. However, some factors such as trauma, aging, and repetitive or non-repetitive episodes of infections can overwhelm the lymphatic system, changing the balance. Therefore, the longer the time elapsed since surgery, the greater the risk of developing lymphedema, because this increases the chances of a woman being exposed to injury .
Radiotherapy is considered as a risk factor for development of lymphedema, mainly when axillary irradiation is applied [7, 13, 26]. A likely explanation is the occurrence of lymphedema due to the blockage of lymph vessels or their compression by fibrosis caused by this treatment [25, 27, 28]. According to Bergmann et al.,  the main risk factor associated with lymphedema after treatment for breast cancer is the axillary approach, both surgical and radiotherapy, followed by age. Our study differs from previous studies in that there was no association between the irradiation site and the development of morbidity when controlled by other variables.
AWS, otherwise known as superficial lymphatic thrombosis, is the formation of a palpable network of cords that can extend from the armpit, through the antecubital space to the base of the thumb. AWS is caused by possible formation and displacement of fibrin clots in the superficial veins and lymphatic capillaries, which form a network [8, 20, 29]. In the current study, the presence of AWS in bivariate analysis was statistically significant (p<0.001). However, when AWS was analyzed in the adjusted model, it lost its significance. This syndrome is accompanied by acute pain symptoms that may regress spontaneously (~3 months after surgery) or become chronic, when the formation of a fibrotic cord occurs, and this restricts the range of motion of the shoulder [30, 31]. The presence of AWS contributes to the formation or worsening of lymphedema [26, 29, 31].
Some studies question the validity of current guideline “manuals” for the prevention of lymphedema, because they believe that despite the biological plausibility, no evidence has been shown for the validity of these treatments [6, 7, 32]. Therefore, it is prudent for the patient to take certain care of the arm, but this should not affect or impair the patient’s daily routine. The occurrence of minor injuries, such as cuts, bruises, minor burns, and infection, triggers an inflammatory response. This translates into an increase of fluid filtered by the arterial capillaries into the interstitium, capillaries and lymphatic vessels, which overloads the lymphatic system already damaged by lymphadenectomy [10, 12, 20, 24]. This process may intensify, generating local symptoms, as well as general symptoms, giving rise to the appearance of erysipelas and/or lymphangitides [20, 25, 27]. The removal of cuticles during nail care allows easy access to bacteria, by producing a skin lesion, facilitating an inflammatory process that can precede or aggravate lymphedema [4, 19, 26].
The prevalence of moderate to severe symptoms in women who avoid movement of the ipsilateral arm after surgery is significantly higher than in those who do not avoid it. These data are corroborated by several studies [6, 9, 16, 20] in which changes in movements of the shoulder after surgery for breast cancer were investigated, at various times after surgery, to determine the effect of early exercise intervention through physiotherapy [18, 32, 33]. In the present study, only 119 women (47.6%) received some type of information concerning various treatments for the limb and the importance of early motion. In this case, besides harm from the lack of intervention supervised by a professional, the guidance of self care alone leads to misinterpretation, resulting in failure to perform adequate exercises. Studies of lymphedema have shown a positive association between the receipt of information and the avoidance of movement [7, 16, 20, 34, 35]. In our study, an important association was found between lymphedema and the lack of information regarding movement of the limb, although this was not statistically significant in multivariate analysis.
Lymphedema is a multifactorial morbidity. Therefore, an interdisciplinary approach is required. The prevalence of 44.8% for lymphedema found in this study is considered relevant because it is a morbidity that produces psychological, physical, and functional damage in patients with this condition. Lymphedema is associated with the time elapsed after surgery, associated vascular pathologies, the presence of seroma, episodes of redness in some parts of the limb after surgery, and cuticle removal with pliers from the hand ipsilateral to the surgery. The surgical method, as well as the extent of the axillary approach, the area administered radiotherapy, and application of chemotherapy show a positive, but not significant, association with the presence of lymphedema.
We conclude that lymphedema is a preventable morbidity. The planning of health programs and services appropriate to the immediate postoperative treatment of women with breast cancer, and increasing the awareness of health professionals regarding the early diagnosis of lymphedema, can help minimize morbidity. Understanding and improved definitions of the associated factors could be important tools for treatment of this condition.
DMFP is a professor at the School of Medical Sciences and Health, Juiz de Fora, SUPREMA, Brazil. VOR is a graduate student at the School of Medicine, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, UFJF, Brazil. MGC is a graduate student at the School of Medicine, Institutional Programs for Scientific Start-up Grants (XXII BIC/UFJF), Federal University of Juiz de Fora, UFJF, Brazil. PVP is a graduate student at the School of Dentistry, Institutional Programs for Scientific Start-up Grants (XX PIBIC/UFJF), Federal University of Juiz de Fora, UFJF, Brazil. ICG has a doctorate in public health, and is an adjunct professor of the Public Health Department of the School of Medicine, Federal University of Juiz de Fora, UFJF, Brazil.
Axillary Web Syndrome
Sentinel lymph node.
Ministério da Saúde (Brasil). Instituto Nacional de Câncer: Estimativas da Incidência e mortalidade por Câncer no Brasil. 2010, Rio de Janeiro: INCA
Guerra MR, Mendonça GAS, Bustamante-Teixeira MT, Cintra JRD, Carvalho LM, Magalhães LMPV: Sobrevida de cinco anos e fatores prognósticos em coorte de pacientes com câncer de mama assistidas em Juiz de Fora, Minas Gerais. Brasil. Cad Saúde Publica. 2009, 25: 2455-2466. 10.1590/S0102-311X2009001100015.
Beaulac SM, McNair LA, Scott TE, LaMorte WW, Kavanah MT: Lymphedema and quality of life in survivors of early-stage breast cancer. Arch Surg. 2002, 137: 1253-1257. 10.1001/archsurg.137.11.1253.
Dayes IS, Levine MN, Julian JA, Pritchard KI, D’Souza DP, Kligman L, et al: Lymphedema in women with breast cancer: characteristics of patients screened for a randomized trial. Breast Cancer Res Treat. 2008, 110: 337-342. 10.1007/s10549-007-9727-0.
Sampaio EBM, Albuquerque IMAN, Linhares JJ: Assessing the quality of life in women with breast cancer through the questionnaire SF-36. Appl Cancer Res. 2008, 28: 93-98.
Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D: Axilla surgery severely affects quality of life: results of a 5-year prospective study in breast cancer patients. Breast Cancer Res Treat. 2003, 79: 47-57. 10.1023/A:1023330206021.
Bergmann A, Mattos IE, Koiffman RJ, Ribeiro MJP: Upper limb lymphedema following breast cancer surgery: prevalence and associated factors. Lymphology. 2008, 40 (Suppl): 96-106.
Buchholz T, Avristscher R, Yu TK: Identifying the “sentinel lymph nodes” for arm drainage as strategy for minimizing the lymphedema risk after breast cancer therapy. Breast Cancer Res Treat. 2009, 116: 539-541. 10.1007/s10549-009-0324-2.
Stanton AW, Modi S, Mellor RH, Levick JR, Mortimer PS: Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol. 2009, 7: 29-45. 10.1089/lrb.2008.1026.
Armer JM, Stewart BR: Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology. 2010, 43: 118-127.
Gartner R, Jesse MB, Kronborg L, Ewertz M, Kehlet H, Kromann: Self-reported arm-lymphedema and impairment after breast cancer treatment – a national study of prevalence and associated factors. Breast. 2010, 19: 506-515. 10.1016/j.breast.2010.05.015.
Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, et al: Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer. 2004, 41: 8-12.
Soran A, Wu WC, Dirican A, Johnson R, Andacoglu O, Wilson J: Estimating the probability of lymphedema after breast cancer surgery. Am J Clin Oncol. 2010, Epub ahead of print
Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, et al: Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol. 2009, 27: 390-397.
Kwan ML, Darbinian J, Schmitz KH, Citron R, Partee P, Kutner SE, et al: Risk factors for lymphedema in a prospective breast cancer survivorship study: the pathways study. Arch Surg. 2010, 145: 1055-1063. 10.1001/archsurg.2010.231.
Hayes SC, Janda M, Cornish B, Battistutta D, Newman B: Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol. 2008, 26: 3536-3542. 10.1200/JCO.2007.14.4899.
Hunt KK, Askew R, Cormier JN: Measuring lymphedema in patients with breast cancer: go with the flow?. Breast Cancer Res Treat. 2009, 117: 559-560. 10.1007/s10549-009-0320-6.
Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM: Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer. 2010, 116: 5138-5149. 10.1002/cncr.25458.
Thomas-Maclean RL, Hack T, Kwan W, Towers A, Miedema B, Tilley A: Arm morbidity and disability after breast cancer: new directions for care. Oncol Nurs Forum. 2008, 35: 65-71. 10.1188/08.ONF.65-71.
Tsai RJ, Dennis LK, Lynch CF, Snetselaar LG, Zamba GK, Scott-Conner C: The risk of developing arm lymphedema among breast cancer survivors: a meta-analysis of treatment factors. Ann Surg Oncol. 2009, 16: 1959-1972. 10.1245/s10434-009-0452-2.
Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB: A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol. 2009, 16: 979-988. 10.1245/s10434-009-0347-2.
Shih YC, Xu Y, Cormier JN, Giordano S, Ridner SH, Buchholz TA, et al: Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol. 2009, 27: 2007-2014. 10.1200/JCO.2008.18.3517.
Harmer V: Breast cancer-related lymphoedema: risk factors and treatment. Br J Nurs. 2009, 18: 166-172.
Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, et al: Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev. 2010, 19: 2734-2746. 10.1158/1055-9965.EPI-09-1245.
Clough-Gorr KM, Ganz PA, Silliman RA: Older breast cancer survivors: factors associated with self-reported symptoms of persistent lymphedema over 7 years of follow-up. Breast J. 2010, 16: 147-155. 10.1111/j.1524-4741.2009.00878.x.
Meeske KA, Sullivan-Halley J, Smith AW, McTiernan A, Baumgartner KB, Harlan LC, et al: Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women. Breast Cancer Res Treat. 2009, 113: 383-391. 10.1007/s10549-008-9940-5.
Goffman TE, Laronga C, Wilson L, Elkins D: Lymphedema of the arm and breast in irradiated breast cancer patients: risks in an era of dramatically changing axillary surgery. Breast J. 2004, 10: 405-411. 10.1111/j.1075-122X.2004.21411.x.
Mak SS, Yeo W, Lee YM, Tse SM, Ho FP, Zee B, et al: Risk factors for the initiation and aggravation of lymphoedema after axillary lymph node dissection for breast cancer. Hong Kong Med J. 2009, 15 (3 Suppl 4): 8-12.
Hojris I, Andersen J, Overgaard M, Overgaard J: Late treatment-related morbidity in breast cancer patients randomized to postmastectomy radiotherapy and systemic treatment versus systemic treatment alone. Acta Oncol. 2000, 39: 355-372. 10.1080/028418600750013131.
Bergmann A, Mattos IE, Koiffman RJ, Ribeiro MJP, Nogueira EA, Ribeiro EP, et al: Axillary web syndrome after lumpnode dissection: results for 1004 breast cancer patients. Lymphology. 2007, 40 (Suppl): 198-203.
Leidenius M, Leppänen E, Krogerus L, von Smitten K: Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg. 2003, 185: 127-130. 10.1016/S0002-9610(02)01214-X.
Moskovitz AH, Anderson BO, Yeung RS, Byrd DR, Lawton TJ, Moe RE: Axillary web syndrome after axillary dissection. Am J Surg. 2001, 181: 434-439. 10.1016/S0002-9610(01)00602-X.
Johansen J, Overgaard J, Blichert-Toft M, Overgaard M: Treatment of morbidity associated with the management of the axilla in breast-conserving therapy. Acta Oncol. 2000, 39: 349-354. 10.1080/028418600750013122.
Mutrie N, Campbell AM, Whyte F, McConnachie A, Emslie C, Lee L, et al: Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial. BMJ. 2007, 334: 517-10.1136/bmj.39094.648553.AE.
Beurskens CH, van Uden CJ, Strobbe LJ, Oostendorp RA, Wobbes T: The efficacy of physiotherapy upon shoulder function following axillary dissection in breast cancer, a randomized controlled study. BMC Cancer. 2007, 7: 166-10.1186/1471-2407-7-166.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6874/13/6/prepub
The authors declare that they have no competing financial interests.
DMFP conceived the study and participated in the study design, analysis, and drafting of the manuscript. VOR, MGC, and PVP participated in the study design, and performed statistical analysis and data collection. ICG participated in the study design, coordination, and analysis, and drafting of the manuscript. All authors read and approved the final manuscript.
About this article
Cite this article
Paiva, D.M., Rodrigues, V.O., Cesca, M.G. et al. Prevalence of lymphedema in women undergoing treatment for breast cancer in a referral center in southeastern Brazil. BMC Women's Health 13, 6 (2013). https://doi.org/10.1186/1472-6874-13-6
- Risk factors
- Cross-seccional study